NodThera Named a ‘Fierce 15’ Company by Fierce Biotech
August 6, 2024
Philadelphia, PA, August 5, 2024 – NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic inflammatory diseases through selective modulation of the NLRP3